Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients

BACKGROUND: Diabetes is a risk factor for the progression and prognosis of coronavirus disease (COVID-19), but the relationship between glycosylated hemoglobin (HbA1c) level, inflammation, and prognosis of COVID-19 patients has not been explored. METHODS: This was a retrospective study of COVID-19 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhenzhou, Du, Zhe, Zhu, Fengxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233217/
https://www.ncbi.nlm.nih.gov/pubmed/32416121
http://dx.doi.org/10.1016/j.diabres.2020.108214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233217/
https://www.ncbi.nlm.nih.gov/pubmed/32416121
http://dx.doi.org/10.1016/j.diabres.2020.108214

Ejemplares similares